OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. A variety of strategies have been employed to antibody titer, comprising process parameter optimization, cell line development, and the use of perfusion processes. Fine-tuning media composition